These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5673236)

  • 1. Hexamethylmelamine (NSC-13875) in the treatment of primary cancer of the lung with metastasis.
    De la Garza JG; Carr DT; Bisel HF
    Cancer; 1968 Sep; 22(3):571-5. PubMed ID: 5673236
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.
    Richards F; Pajak TF; Cooper MR; Spurr CL
    Cancer Chemother Rep; 1973; 57(4):419-22. PubMed ID: 4357670
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of far-advanced carcinoma of the lung.
    Schell HW; Cressy NL
    Geriatrics; 1966 May; 21(5):146-50. PubMed ID: 4160279
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
    Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
    Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polychemotherapy of malignant tumors and hemoblastoses].
    Kühböck J; Pokorny D; Steinbach K; Eggerth G
    Wien Z Inn Med; 1968; 49(12):449-61. PubMed ID: 4311394
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of malignant renal tumors.
    Jussawalla DJ; Bhansali SK
    Indian J Cancer; 1968 Mar; 5(1):68-71. PubMed ID: 4178652
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2.
    Wilson WL; Ryzin JV; Weiss AJ; Frelick RW; Moss SE
    Oncology; 1975; 31(5-6):293-309. PubMed ID: 174041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minimal useful dose of combined cytostatics in the treatment of inoperable pulmonary cancer].
    Rodriguez AR; Rodriguez MD; Calderon EP; Santamaria JE; Jimenez OP
    Poumon Coeur; 1968; 24(1):125-7. PubMed ID: 5652198
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experiences with dibromodulcitol (NSC-104800) in solid tumors.
    Phillips RW; Brook J
    Cancer Chemother Rep; 1971 Dec; 55(5):567-73. PubMed ID: 4946081
    [No Abstract]   [Full Text] [Related]  

  • 10. Carotid transposition for cancer chemotherapy.
    Donaldson RC; Paletta FX
    Am J Surg; 1967 Oct; 114(4):559-63. PubMed ID: 4166919
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercalcemic crisis in neoplastic diseases: management with mithramycin.
    Elias EG; Evans JT
    Surgery; 1972 Apr; 71(4):631-5. PubMed ID: 4259864
    [No Abstract]   [Full Text] [Related]  

  • 12. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 13. Hexamethylmelamine in inoperable bronchogenic carcinoma.
    Takita H
    N Y State J Med; 1972 Feb; 72(4):477-80. PubMed ID: 4334448
    [No Abstract]   [Full Text] [Related]  

  • 14. cis-Dichlorodiammineplatinum(II) and hexamethylmelamine in the treatment of non-oat cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
    Krauss S; Tornyos K; DeSimone P; Lowenbraun S; McKeown J; Solomon A; Sonoda T
    Cancer Treat Rep; 1979 Mar; 63(3):391-3. PubMed ID: 106964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylating agents in bronchogenic carcinoma.
    Green RA; Humphrey E; Close H; Patno ME
    Am J Med; 1969 Apr; 46(4):516-25. PubMed ID: 5791000
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary trials with a combination of adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies.
    Tormey DC; Bergevin P; Blom J; Petty W
    Cancer Chemother Rep; 1973; 57(4):413-8. PubMed ID: 4128422
    [No Abstract]   [Full Text] [Related]  

  • 17. [218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
    Israel L; Bernard E
    Poumon Coeur; 1968; 24(1):63-8. PubMed ID: 5690023
    [No Abstract]   [Full Text] [Related]  

  • 18. Epodyl (AY 62013) in advanced cancer involving the brain and other organs.
    Horton J; Olson KB; Cunningham TJ; Sullivan JM
    Cancer; 1967 Nov; 20(11):1837-40. PubMed ID: 6061620
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M; Muggia FM; Ackerman C
    Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary phase II study of adriamycin (ADM) in patients with non-small cell lung cancer (NSCLC).
    Fujita J; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Sakurai M; Futami H; Ishihara J; Takahashi H
    Jpn J Clin Oncol; 1985 Jun; 15(2):365-8. PubMed ID: 4021119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.